Nord-Trondelag Hospital Trust — Clinical Trial Site

11 Registered trials

4 Currently recruiting

Organisation

Nord-Trondelag Hospital Trust

Location

Levanger, Norway

Identifier

ORG-100043337

Address

Kirkegata 2, 7600, Norway

Departments

Department of Internal Medicine
Department of Neurology
department of oncology
Department of Pulmonology
Helse Nord-Troendelag Thrust
Hematology
Medisinsk avdeling
Medisinsk avdeling, Gastroseksjonen
Neurology
Oncology

Clinical trials at this site (11)

Search interface

Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe… Pending

2024-518420-80-00 Primary infection prophylaxis for secondary immunodefic 5
Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) – a Pragmatic Randomized Controlled Tri… Recruiting

2023-505573-32-00 Immune Thrombocytopenia (ITP) 5 2025-07-01
The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind tr… Recruiting

2024-517981-40-00 Chronic Migraine 5 2025-06-06
Precision cancer medicine in hard-to-treat rare cancers - repurposing drugs in earlier lines of treatment - MATRIX-RARE. Recruiting

2024-513779-42-02 Cancer 4 2025-03-27
Improving public cancer care by implementing precision medicine in Norway Recruiting

2023-507894-16-00 Cancer 4 2021-04-01
RElapse from Mrd Negativity As iNdication for Treatment Ended

2023-510215-18-00 Multiple myeloma 10 2024-09-26
Is there a survival benefit of administering thoracic radiotherapy concurrently with immunnotherapy and chemotherapy for patients with exten… Ended

2023-505514-15-00 Small-cell lung cancer, extensive stage 5 2022-01-11
Ocrelizumab VErsus Rituximab off-Label at the Onset of Relapsing MS Disease (OVERLORD-MS) Ended

2024-510716-71-00 Multiple Sclerosis 5 2020-10-21
A randomized phase II study comparing atezolizumab after concurrent chemoradiotherapy with chemoradiotherapy alone in limited disease small-… Ended

2024-515755-37-00 Limited disease small-cell lung cancer 4 2018-07-31
A Placebo controlled Maintenance and Long-term Extension Study of the Efficacy and Safety of Risankizumab in Participants with Crohn's Disea… Ended

2023-506399-28-00 Crohn's Disease 5 2017-11-08
Efficacy and safety of UV1 vaccination +/- standard of care as first line treatment of patients with non-small cell lung cancer Ended

2022-502437-25-00 advanced or metastatic non-small cell lung cancer 4 2022-08-15